Cipla Q4 Outcomes: Earnings Falls 33%, Margin Contracts

Cipla Q4 Outcomes: Earnings Falls 33%, Margin Contracts

Bloomberg the Company & Its ProductsThe QuintBloomberg Bloomberg | Quint is a multiplatform, Indian business and financial news company. We combine Bloomberg’s global leadership in business and financial news and data, with Quintillion Media’s deep expertise in the Indian market and digital news delivery, to provide high quality business news, insights and trends for India’s…

View More Cipla Q4 Outcomes: Earnings Falls 33%, Margin Contracts
Cipla experiences Q4 earnings at Rs 246 crore, FY20 accept grows 1% to Rs 1,547 crore

Cipla experiences Q4 earnings at Rs 246 crore, FY20 accept grows 1% to Rs 1,547 crore

Pharma company Cipla declared a profit after tax of Rs 246 crore for the quarter ended March 2020, declining 33 percent YoY due to high base in Q4FY19.It had a profit of Rs 367.20 crore in the year-ago period, which was bolstered by the company’s US business after the launch of generic Senipar during the quarter.Revenue from operations…

View More Cipla experiences Q4 earnings at Rs 246 crore, FY20 accept grows 1% to Rs 1,547 crore